ClinicalTrials.Veeva

Menu

A Combined Supplementation of Rosemary and Daylily for Enhancing Sleep Quality in Middle-Aged Adults (RESTORE-ENG)

U

University of Novi Sad, Faculty of Sport and Physical Education

Status

Completed

Conditions

Sleep

Treatments

Dietary Supplement: Dietary Supplement: medium-dose Rosemary and Daylily extract
Dietary Supplement: Dietary Supplement: control
Dietary Supplement: Dietary Supplement: low-dose Rosemary and Daylily extract

Study type

Interventional

Funder types

Other

Identifiers

NCT06859879
51-02-18

Details and patient eligibility

About

This study aims to investigate the impact of supplementation with two different doses of Rosemary and Daylily herbal extract on various health outcomes in middle-aged adults. Over an eight-week period, the trial will assess improvements in sleep quality, circadian rhythms, energy metabolism, and relevant biochemical markers. The study employs a randomized, placebo-controlled, crossover design to evaluate the efficacy of these supplements in enhancing overall health and well-being.

Enrollment

10 patients

Sex

All

Ages

50+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age > 50 years
  • Trouble falling asleep > 5 times a month (NHANES criteria)
  • Body mass index 18.5-29.9 kg/m2
  • Free of major chronic diseases or acute disorders
  • Given written informed consent

Exclusion criteria

  • History of dietary supplement use > 2 weeks before the study commences
  • Abnormal values for lab clinical chemistry (> 2 SD)
  • Unwillingness to return for follow-up analysis
  • Participation in other clinical trials
  • Moderate-to-heavy use of alcohol (> 3 drinks per week)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

10 participants in 3 patient groups, including a placebo group

Experimental 1: Low-dose
Experimental group
Description:
One capsule of active Rosemary and Daylily extract and one placebo capsule
Treatment:
Dietary Supplement: Dietary Supplement: low-dose Rosemary and Daylily extract
Experimental 2: Medium-dose
Experimental group
Description:
Two capsules of active Rosemary and Daylily extract
Treatment:
Dietary Supplement: Dietary Supplement: medium-dose Rosemary and Daylily extract
Experimental 3: Control
Placebo Comparator group
Description:
Two capsules of placebo
Treatment:
Dietary Supplement: Dietary Supplement: control

Trial contacts and locations

1

Loading...

Central trial contact

Sergej M Ostojic, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems